An update from Beauty Health ( (SKIN) ) is now available.
The Beauty Health Company announced the termination of its Chief Revenue Officer, Daniel Watson, effective October 14, 2024, with no disagreements over company operations or financial practices. Watson will transition to an advisory role until the end of the year, and a separation agreement detailing his exit benefits is forthcoming.
See more insights into SKIN stock on TipRanks’ Stock Analysis page.
